# Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

> **NCT07383649** · PHASE2 · RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 28 (estimated)

## Conditions studied

- Brain Cancer Metastatic
- CMV Viremia

## Interventions

- **DRUG:** Valganciclovir

## Key facts

- **NCT ID:** NCT07383649
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-05
- **Final completion:** 2030-05
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07383649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07383649, "Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT07383649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*